| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |